This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Hoffmann-La Roche Inc., Les Hôpitaux Universitaires De Genève, Universitè De Genève. Active years: 2018.
Company Filing History:
1 out of 5,020 
1 out of 8 
1 out of 71 
Years Active: 2018
Title: The Innovations of Nicolas Vuilleumier
Introduction
Nicolas Vuilleumier is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of biomedical research, particularly in the area of cardiovascular health. His innovative work has led to the development of valuable diagnostic tools.
Latest Patents
Nicolas Vuilleumier holds a patent for mimetic peptides. This invention relates to mimetic peptides of epitope(s) of Apolipoprotein A-I. It includes diagnostic immunoassays that utilize these mimetic peptides, as well as methods for diagnosing and preventing or treating cardiovascular diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Vuilleumier has worked with prestigious institutions such as Les Hôpitaux Universitaires de Genève and the University of Geneva. His work in these organizations has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Nicolas Vuilleumier has collaborated with several professionals in his field, including Sabrina Pagano and Oliver Hartley. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Nicolas Vuilleumier's contributions to the field of biomedical research, particularly through his patent on mimetic peptides, highlight his role as an innovative inventor. His work continues to influence the diagnosis and treatment of cardiovascular diseases.